vs
Side-by-side financial comparison of Douglas Elliman Inc. (DOUG) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
Douglas Elliman Inc. is the larger business by last-quarter revenue ($245.4M vs $164.7M, roughly 1.5× PTC THERAPEUTICS, INC.). Douglas Elliman Inc. runs the higher net margin — 27.9% vs -82.0%, a 109.9% gap on every dollar of revenue. On growth, Douglas Elliman Inc. posted the faster year-over-year revenue change (0.9% vs -22.7%). Douglas Elliman Inc. produced more free cash flow last quarter ($-14.7M vs $-36.6M). Over the past eight quarters, Douglas Elliman Inc.'s revenue compounded faster (10.7% CAGR vs -11.5%).
Douglas Elliman Inc. is a leading U.S.-based residential real estate brokerage firm. It offers luxury property sales, rentals, property management, and advisory solutions, serving high-net-worth clients across key metro markets including New York, California, Florida, and Texas.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
DOUG vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $245.4M | $164.7M |
| Net Profit | $68.6M | $-135.0M |
| Gross Margin | — | — |
| Operating Margin | 27.3% | -43.3% |
| Net Margin | 27.9% | -82.0% |
| Revenue YoY | 0.9% | -22.7% |
| Net Profit YoY | 1243.4% | -104.8% |
| EPS (diluted) | $0.80 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $245.4M | $164.7M | ||
| Q3 25 | $262.8M | $211.0M | ||
| Q2 25 | $271.4M | $178.9M | ||
| Q1 25 | $253.4M | $1.2B | ||
| Q4 24 | $243.3M | $213.2M | ||
| Q3 24 | $266.3M | $196.8M | ||
| Q2 24 | $285.8M | $186.7M | ||
| Q1 24 | $200.2M | $210.1M |
| Q4 25 | $68.6M | $-135.0M | ||
| Q3 25 | $-24.7M | $15.9M | ||
| Q2 25 | $-22.7M | $-64.8M | ||
| Q1 25 | $-6.0M | $866.6M | ||
| Q4 24 | $-6.0M | $-65.9M | ||
| Q3 24 | $-27.2M | $-106.7M | ||
| Q2 24 | $-1.7M | $-99.2M | ||
| Q1 24 | $-41.5M | $-91.6M |
| Q4 25 | 27.3% | -43.3% | ||
| Q3 25 | -4.1% | 1.4% | ||
| Q2 25 | -2.0% | -19.5% | ||
| Q1 25 | -2.1% | 82.5% | ||
| Q4 24 | -6.7% | -76.2% | ||
| Q3 24 | -2.8% | -27.7% | ||
| Q2 24 | -1.3% | -21.5% | ||
| Q1 24 | -20.7% | -21.6% |
| Q4 25 | 27.9% | -82.0% | ||
| Q3 25 | -9.4% | 7.5% | ||
| Q2 25 | -8.4% | -36.3% | ||
| Q1 25 | -2.4% | 73.7% | ||
| Q4 24 | -2.5% | -30.9% | ||
| Q3 24 | -10.2% | -54.2% | ||
| Q2 24 | -0.6% | -53.1% | ||
| Q1 24 | -20.7% | -43.6% |
| Q4 25 | $0.80 | $-1.63 | ||
| Q3 25 | $-0.29 | $0.20 | ||
| Q2 25 | $-0.27 | $-0.83 | ||
| Q1 25 | $-0.07 | $10.04 | ||
| Q4 24 | $-0.06 | $-0.85 | ||
| Q3 24 | $-0.33 | $-1.39 | ||
| Q2 24 | $-0.02 | $-1.29 | ||
| Q1 24 | $-0.50 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $115.5M | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $183.9M | $-205.3M |
| Total Assets | $444.4M | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $115.5M | $1.9B | ||
| Q3 25 | $143.0M | $1.7B | ||
| Q2 25 | $136.3M | $2.0B | ||
| Q1 25 | $136.8M | $2.0B | ||
| Q4 24 | $145.5M | $1.1B | ||
| Q3 24 | $151.4M | $1.0B | ||
| Q2 24 | $92.9M | $1.1B | ||
| Q1 24 | $91.5M | $884.8M |
| Q4 25 | $183.9M | $-205.3M | ||
| Q3 25 | $115.1M | $-155.8M | ||
| Q2 25 | $137.6M | $-206.5M | ||
| Q1 25 | $158.2M | $-185.8M | ||
| Q4 24 | $162.2M | $-1.1B | ||
| Q3 24 | $173.6M | $-1.1B | ||
| Q2 24 | $196.9M | $-980.2M | ||
| Q1 24 | $195.1M | $-893.9M |
| Q4 25 | $444.4M | $2.9B | ||
| Q3 25 | $480.6M | $2.6B | ||
| Q2 25 | $489.0M | $2.6B | ||
| Q1 25 | $493.9M | $2.7B | ||
| Q4 24 | $493.9M | $1.7B | ||
| Q3 24 | $502.7M | $1.8B | ||
| Q2 24 | $463.9M | $1.9B | ||
| Q1 24 | $461.1M | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-14.4M | $-34.3M |
| Free Cash FlowOCF − Capex | $-14.7M | $-36.6M |
| FCF MarginFCF / Revenue | -6.0% | -22.3% |
| Capex IntensityCapex / Revenue | 0.1% | 1.4% |
| Cash ConversionOCF / Net Profit | -0.21× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-17.2M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-14.4M | $-34.3M | ||
| Q3 25 | $5.5M | $-66.3M | ||
| Q2 25 | $642.0K | $-58.3M | ||
| Q1 25 | $-5.6M | $870.1M | ||
| Q4 24 | $-9.0M | $-30.0M | ||
| Q3 24 | $9.0M | $-77.0M | ||
| Q2 24 | $1.3M | $-71.5M | ||
| Q1 24 | $-27.3M | $70.8M |
| Q4 25 | $-14.7M | $-36.6M | ||
| Q3 25 | $4.7M | $-69.7M | ||
| Q2 25 | $-575.0K | $-59.6M | ||
| Q1 25 | $-6.7M | $868.4M | ||
| Q4 24 | $-10.2M | $-33.8M | ||
| Q3 24 | $7.7M | $-77.5M | ||
| Q2 24 | $432.0K | $-78.8M | ||
| Q1 24 | $-29.4M | $61.2M |
| Q4 25 | -6.0% | -22.3% | ||
| Q3 25 | 1.8% | -33.1% | ||
| Q2 25 | -0.2% | -33.3% | ||
| Q1 25 | -2.6% | 73.8% | ||
| Q4 24 | -4.2% | -15.8% | ||
| Q3 24 | 2.9% | -39.4% | ||
| Q2 24 | 0.2% | -42.2% | ||
| Q1 24 | -14.7% | 29.1% |
| Q4 25 | 0.1% | 1.4% | ||
| Q3 25 | 0.3% | 1.6% | ||
| Q2 25 | 0.4% | 0.7% | ||
| Q1 25 | 0.4% | 0.1% | ||
| Q4 24 | 0.5% | 1.8% | ||
| Q3 24 | 0.5% | 0.3% | ||
| Q2 24 | 0.3% | 4.0% | ||
| Q1 24 | 1.0% | 4.6% |
| Q4 25 | -0.21× | — | ||
| Q3 25 | — | -4.17× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DOUG
| Commissions And Other Brokerage Income | $240.3M | 98% |
| Property Management Income | $2.8M | 1% |
| Property Management | $2.2M | 1% |
PTCT
Segment breakdown not available.